Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penile Rehabilitation After Nerve-Sparing Robot-Assisted Radical Prostatectomy 2.0
NL-OMON56218Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sildenafil and papaverine + phentolamine in erectile dysfunction (ED), sponsored by Netherlands Cancer Institute. Primary endpoint: Adequate unassisted erection at 24 months after surgery. Started Jan 2024; status: active, not recruiting.
02
Drugs
sildenafilpapaverine + phentolamine
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NL-OMON56218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56218.